Bright Minds Biosciences (DRUG) News Today → Thousands of investors use this no cost solution | Do you? (From Insider Financial) (Ad) Free DRUG Stock Alerts $1.09 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePsyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And Moremsn.com - January 12 at 7:02 PMBright Minds Announces Non-Brokered Private Placement Fully Subscribed by Managementfinance.yahoo.com - December 6 at 5:33 PMPsyched: Veterans & Psychedelics, $100M IPO, Cybin's $64M Offering, Worldwide Events & Moremsn.com - November 12 at 11:09 PMBright Minds Biosciences Inc. (DRUG.CN)finance.yahoo.com - November 12 at 12:51 AMBright Minds Biosciences Stock (NASDAQ:DRUG) Dividends: History, Yield and Datesbenzinga.com - October 25 at 9:57 AMDRUG Bright Minds Biosciences Inc.seekingalpha.com - August 18 at 6:01 PMBright Minds stock rallies ahead of conference call to discuss Phase 1 datamsn.com - August 8 at 3:05 PMBright Minds Biosciences Announces Positive qEEG (Quantitative Electroencephalogram) Data from its First-in-Human Phase 1 Study of Lead Compound, BMB-101finance.yahoo.com - August 8 at 10:05 AMBright Minds reports results from trial to treat refractory epilepsiesmsn.com - August 7 at 11:04 AMCybin, Bright Minds And PharmAla: A Short Recap On Progress Within Clinical Trialsbenzinga.com - July 24 at 7:47 PMBright Minds Biosciences Announces Positive Topline Data for its First-in-Human Phase 1 Study of Lead Compound, BMB-101finance.yahoo.com - July 20 at 7:48 AMBright Minds Biosciences Stock (NASDAQ:DRUG), Short Interest Reportbenzinga.com - July 12 at 9:18 AMBright Minds Goes For 5:1 Shares Consolidation, Hopes To Regain NASDAQ Compliancemsn.com - July 11 at 7:12 PMBright Minds Biosciences: Bright Minds Announces Effective Date of Share Consolidationfinanznachrichten.de - July 11 at 9:11 AMBright Minds Biosciences: Bright Minds Announces Proposed Share Consolidationfinanznachrichten.de - June 22 at 2:29 PMBright Minds Announces Proposed Share Consolidationfinance.yahoo.com - June 22 at 8:04 AMBright Minds Biosciences Stock (NASDAQ:DRUG), Earnings Estimates, EPS, and Revenuebenzinga.com - May 16 at 12:26 PMBright Minds Biosciences Stock (NASDAQ:DRUG), Analyst Ratings, Price Targets, Predictionsbenzinga.com - April 20 at 10:29 AMBright Minds Biosciences Stock (NASDAQ:DRUG), Trade Ideasbenzinga.com - April 19 at 6:38 PMBright Minds Biosciences Receives a Favorable Written Opinion from the International Searching Authority for BMB-202finance.yahoo.com - April 19 at 8:10 AMBright Minds Biosciences to Present at the 20th International Meeting of the International Society for Serotonin Researchfinance.yahoo.com - April 10 at 11:23 AMBright Minds Biosciences Provides Clinical Program Updates and Outlines Anticipated Milestones for 2023finance.yahoo.com - February 27 at 7:35 AMBright Minds Biosciences Announces Receipt of Nasdaq Deficiency Letter Regarding Independent Director and Audit Committee Requirementsfinance.yahoo.com - February 8 at 5:44 PMBright Minds Biosciences Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiencyfinance.yahoo.com - January 27 at 6:30 PMBright Minds Biosciences Announces Closing of Non-Brokered Private Placementfinance.yahoo.com - December 2 at 7:48 PMBright Minds Biosciences Announces Non-Brokered Private Placementfinance.yahoo.com - November 28 at 4:19 PMBright Minds Biosciences Appoints Drug Development Executive Mark A. Smith M.D., Ph.D. as Chief Medical Officerfinance.yahoo.com - November 23 at 4:34 PMThinking about buying stock in Akouos, Federated National, Bright Minds Biosciences, VNET Group, or MFA Financial?benzinga.com - October 18 at 10:29 AMBright Minds Biosciences Inc. (DRUG)finance.yahoo.com - September 26 at 10:53 PMBright Minds Biosciences Announces Appointment of Doug Williamson to Board of Directorsfinance.yahoo.com - September 7 at 7:07 AMBright Minds Biosciences Shares Drop 22% After Epileptic Drug Dosing, Closed Offeringmarketwatch.com - August 31 at 6:30 PMNasdaq-listed Bright Minds Closes $4 Million Offering And Begins Dosing In Clinical Trial For Epilepsybenzinga.com - August 31 at 5:10 PMBright Minds Biosciences Initiates Dosing in Phase I Clinical Trial of BMB-101 for Dravet Syndromefinance.yahoo.com - August 31 at 8:44 AMBright Minds Biosciences Announces Closing of $4 Million Unit Offeringfinance.yahoo.com - August 30 at 5:42 PMThinking about buying stock in Bright Minds Biosciences, Futu Holdings, Zhihu, Tencent Music Entertainment, or IQIYI?marketwatch.com - August 27 at 11:18 PMBright Minds Announces Pricing of Overnight Marketed Offering of Unitsfinance.yahoo.com - August 23 at 11:47 PMBright Minds Announces Overnight Marketed Offering of Unitsfinance.yahoo.com - August 22 at 11:12 PMBright Minds Biosciences Inc.barrons.com - August 22 at 6:11 PMBright Minds Biosciences Comments on Recent Trading Activityfinance.yahoo.com - August 18 at 6:12 PMmarketbeat.com - August 18 at 9:57 AMmarketbeat.com - August 18 at 9:43 AMBright Minds Biosciences names Jan Torleif Pedersen as interim science chiefseekingalpha.com - June 27 at 11:45 AMBright Minds Biosciences Announces Changes to its Executive Leadership Team, Marking the Transition to a Development Organizationfinance.yahoo.com - June 27 at 11:45 AMBright Minds Biosciences to Host Key Opinion Leader Symposium on Dravet Syndromefinance.yahoo.com - May 12 at 7:38 AMBright Minds Biosciences Inc (DRUG)investing.com - May 2 at 10:45 PMBright Minds Biosciences Provides Scientific Update on its Novel 5-HT2A Psychedelic Program for the Treatment of Mental Diseasesfinance.yahoo.com - April 27 at 7:56 PMBright Minds Biosciences to Present at the Stifel GMP 2nd Annual Future of Healthcare Conferencefinance.yahoo.com - April 27 at 7:56 PMCanadian Securities Exchange's November 2021 Performance Includes Strong Listings Growth and New Financing Milestonefinance.yahoo.com - April 27 at 7:56 PMBright Minds Biosciences to Present at the H.C. Wainwright Bioconnect Conferencefinance.yahoo.com - April 27 at 7:56 PMBright Minds Biosciences to Present at the Oppenheimer 32nd Annual Healthcare Conferencefinance.yahoo.com - April 27 at 7:56 PM Get Bright Minds Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for DRUG and its competitors with MarketBeat's FREE daily newsletter. Email Address $25,000 into $109,616 in two months? (Ad)Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time… Go here to watch the most recent trading workshop video at no charge. DRUG Media Mentions By Week DRUG Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DRUG News Sentiment▼0.000.37▲Average Medical News Sentiment DRUG News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DRUG Articles This Week▼10▲DRUG Articles Average Week Get Bright Minds Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for DRUG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Synaptogenix News Today LumiraDx News Today GT Biopharma News Today China Pharma News Today Sonnet BioTherapeutics News Today Soligenix News Today PaxMedica News Today Petros Pharmaceuticals News Today Kineta News Today Seelos Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DRUG) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bright Minds Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
